A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Conditions: Breast Cancer; Brain Metastases; Radiotherapy Interventions: Drug: Combination use of SRT with T-DXd Sponsors: Fudan University Not yet recruiting

https://clinicaltrials.gov/study/NCT06088056

Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials